263 related articles for article (PubMed ID: 21131930)
1. Editorial: Reflux, dyspepsia, and Rome III (or Rome IV?).
Stanghellini V; Frisoni C
Am J Gastroenterol; 2010 Dec; 105(12):2632-4. PubMed ID: 21131930
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria.
Xiao YL; Peng S; Tao J; Wang AJ; Lin JK; Hu PJ; Chen MH
Am J Gastroenterol; 2010 Dec; 105(12):2626-31. PubMed ID: 20823838
[TBL] [Abstract][Full Text] [Related]
3. Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease.
Mönnikes H; Schwan T; van Rensburg C; Straszak A; Theek C; Sander P; Lühmann R
Aliment Pharmacol Ther; 2012 Jun; 35(11):1279-89. PubMed ID: 22486552
[TBL] [Abstract][Full Text] [Related]
4. Symptom overlap between postprandial distress and epigastric pain syndromes of the Rome III dyspepsia classification.
Vakil N; Halling K; Ohlsson L; Wernersson B
Am J Gastroenterol; 2013 May; 108(5):767-74. PubMed ID: 23567354
[TBL] [Abstract][Full Text] [Related]
5. Observational comparative trial of the efficacy of proton pump inhibitors versus histamine-2 receptor antagonists for uninvestigated dyspepsia.
Nagahara A; Asaoka D; Hojo M; Oguro M; Shimada Y; Ishikawa D; Osada T; Kawabe M; Yoshizawa T; Otaka M; Watanabe S
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S122-8. PubMed ID: 20586853
[TBL] [Abstract][Full Text] [Related]
6. Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.
Zerbib F; Belhocine K; Simon M; Capdepont M; Mion F; Bruley des Varannes S; Galmiche JP
Gut; 2012 Apr; 61(4):501-6. PubMed ID: 21997546
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups?
Hsu YC; Liou JM; Yang TH; Hsu WL; Lin HJ; Wu HT; Lin JT; Wang HP; Wu MS
J Gastroenterol; 2011 Feb; 46(2):183-90. PubMed ID: 20957498
[TBL] [Abstract][Full Text] [Related]
8. Is longer duration of proton pump inhibitor trial better for gastroesophageal reflux disease-related non-cardiac chest pain?
Wu JC
J Gastroenterol Hepatol; 2009 Sep; 24(9):1477-8. PubMed ID: 19743991
[No Abstract] [Full Text] [Related]
9. Frequency and clinical implications of supraesophageal and dyspeptic symptoms in gastroesophageal reflux disease.
Mearin F; Ponce J; Ponce M; Balboa A; Gónzalez MA; Zapardiel J
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):665-74. PubMed ID: 22330237
[TBL] [Abstract][Full Text] [Related]
10. Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett's esophagus.
Neumann H; Monkemuller K; Kandulski A; Malfertheiner P
Dig Dis; 2008; 26(3):243-7. PubMed ID: 18463443
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational study.
Isshi K; Matsuhashi N; Joh T; Higuchi K; Iwakiri K; Kamiya T; Manabe N; Ogawa M; Arihiro S; Haruma K; Nakada K
J Gastroenterol; 2019 Jun; 54(6):492-500. PubMed ID: 30673836
[TBL] [Abstract][Full Text] [Related]
12. Correlation between oesophageal acid exposure and dyspeptic symptoms in patients with nonerosive reflux disease.
Sarnelli G; De Giorgi F; Efficie E; Aprea G; Masone S; Savarese MF; Esposito I; Russo L; Cuomo R
Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):264-8. PubMed ID: 18334868
[TBL] [Abstract][Full Text] [Related]
13. Rabeto plus: a valuable drug for managing functional dyspepsia.
Ghosh A; Halder S; Mandal S; Mandal A; Basu M; Dabholkar P
J Indian Med Assoc; 2008 Nov; 106(11):752-4. PubMed ID: 19368103
[TBL] [Abstract][Full Text] [Related]
14. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
15. Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor.
Takeuchi T; Takahashi Y; Kawaguchi S; Ota K; Harada S; Kojima Y; Sakamoto H; Kuramoto T; Kojima K; Sanomura M; Hoshimoto M; Higashino T; Itabashi T; Takada K; Sakaguchi M; Tominaga K; Kusano M; Higuchi K
J Gastroenterol Hepatol; 2018 Mar; 33(3):623-630. PubMed ID: 28865098
[TBL] [Abstract][Full Text] [Related]
16. The Rome III Classification of dyspepsia: will it help research?
Talley NJ; Ruff K; Jiang X; Jung HK
Dig Dis; 2008; 26(3):203-9. PubMed ID: 18463436
[TBL] [Abstract][Full Text] [Related]
17. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
[TBL] [Abstract][Full Text] [Related]
18. Clinically distinct characteristics in patients younger than 40 years old with non-cardiac chest pain.
Ko SY; Kim SI; Kim JH; Lee JH; Lee KJ; Hong SN; Lee SY; Sung IK; Park HS; Shim CS
J Gastroenterol Hepatol; 2012 Sep; 27(9):1484-9. PubMed ID: 22554344
[TBL] [Abstract][Full Text] [Related]
19. Predicting the efficacy of proton pump inhibitors in patients with non-erosive reflux disease before therapy using dual-channel 24-h esophageal pH monitoring.
Shimatani T; Sugimoto M; Nishino M; Adachi K; Furuta K; Ito M; Kurosawa S; Manabe N; Mannen K; Hongo M; Chiba T; Kinoshita Y;
J Gastroenterol Hepatol; 2012 May; 27(5):899-906. PubMed ID: 22098590
[TBL] [Abstract][Full Text] [Related]
20. Functional dyspepsia: not all roads seem to lead to rome.
van Kerkhoven LA; Laheij RJ; Meineche-Schmidt V; Veldhuyzen-van Zanten SJ; de Wit NJ; Jansen JB
J Clin Gastroenterol; 2009 Feb; 43(2):118-22. PubMed ID: 18719513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
